RBC Europe’s Chembio diagnostics, Inc. CEMI Stock Holding History

RBC Europe’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,430	Closed	-$22.7K	–	1105
2020 Q1	$22.7K	Buy	+4,430	New	+$17.9K	﹤0.01%	534

Other funds holding CEMI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RBC Europe's CEMI Position: Q2 2020 in Review

RBC Europe sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2020, closing a stake of 4,430 shares — an estimated $22.7K sold.

RBC Europe first reported a position in CEMI in Q1 2020 and held it in 1 quarter. The position peaked at $22.7K in Q1 2020. 76 funds tracked by Wall St. Rank hold CEMI as of Q2 2020.

RBC Europe reported no remaining Chembio diagnostics, Inc. position as of Q2 2020 after selling out during the quarter.
RBC Europe sold 4,430 Chembio diagnostics, Inc. shares in Q2 2020, an estimated $22.7K.
RBC Europe first reported a position in Chembio diagnostics, Inc. in Q1 2020 and held it in 1 quarter.
RBC Europe's Chembio diagnostics, Inc. position peaked at $22.7K in Q1 2020.
76 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2020.

Based on RBC Europe's 13F filing for Q2 2020, filed 9 Nov 2023.